AbbVie’s Acquisition of DJS Antibodies

Goodwin Procter advised DJS Antibodies on the deal. AbbVie (NYSE: ABBV) announced the acquisition of DJS Antibodies Ltd (“DJS”), a privately-held UK-based biotechnology company dedicated to discovering...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Accordion’s Acquisition of ABACI

Goodwin Procter advised ABACI on the deal. Accordion, a private equity-focused financial and technology consulting firm, announced that it has acquired ABACI, an Enterprise Resourcing Planning...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here